HIMS Form 4: Okupe Transfers 62,722 Shares, Exercises Options
Rhea-AI Filing Summary
Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), reported transactions on 08/13/2025. The filing shows acquisition of 11,581 shares at an exercise price of $5.01 and a contemporaneous sale of 11,581 shares at a weighted average price of $48.0459, with sales executed in the range $47.84–$48.32. The report also records a transfer of 62,722 Class A shares from the Oluyemi Okupe Separate Property Trust dated 9-1-2021 to the reporting person’s direct holdings. Post-transaction direct beneficial ownership is reported as 65,665 Class A shares. The exercised options referenced vest per a schedule beginning January 24, 2023, with full monthly vesting thereafter and expire February 23, 2032.
Positive
- Transparent disclosure of exercise, sale, and transfer details including price range and vesting schedule
- Use of a 10b5-1 plan (checked on form) indicating transactions were executed under a pre-established plan
- Transfer from trust to direct holdings increases direct ownership visibility (62,722 shares transferred)
Negative
- Insider sale of shares by the CFO reduces his direct trading stake by 11,581 shares
- Material proceeds realized from sale could be perceived as insider monetization (exercise price $5.01 vs sale weighted-average $48.0459)
Insights
TL;DR: CFO exercised options and immediately sold the exercised shares, realizing material value per disclosed prices.
The Form 4 documents an option exercise and a same-day sale of 11,581 Class A shares by the CFO. The exercise price of $5.01 versus the reported weighted-average sale price of $48.0459 implies the insider monetized equity created by prior option grants. The transaction reduces the CFO's direct holdings by the sold amount but was partially offset by a transfer from a family trust, leaving 65,665 shares directly held. The disclosed vesting schedule and long expiration date indicate these options were standard employee awards with multi-year service vesting conditions.
TL;DR: Transaction appears routine under a documented plan with vesting and trust transfer; timely disclosure was made.
The filer checked the box indicating the sale was pursuant to a Rule 10b5-1 plan, suggesting pre-planned execution. The filing includes the required explanatory notes about sale price range and a trust-to-direct transfer of 62,722 shares. Vesting details for the options are disclosed, including the 12-month cliff and monthly vesting thereafter. From a governance perspective, the Form 4 meets standard disclosure elements for insider option exercise, sale, and transfers.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 11,581 | $0.00 | -- |
| Exercise | Class A Common Stock | 11,581 | $5.01 | $58K |
| Sale | Class A Common Stock | 11,581 | $48.0459 | $556K |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $47.84 - $48.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. The balance reflects a transfer of 62,722 shares of Class A Common Stock held by the Oluyemi Okupe Separate Property Trust dtd 9-1-2021 to the Reporting Person's direct holdings. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.
